FAST trial, MMF vs MTX at the Review Course today Overall a big win for MTX, powered for noninferiority (bc people love

Social Author Image
https://pbs.twimg.com/profile_images/956713613854584833/7Vo7a2l5_normal.jpg
Tweet Author
EBRheum
Social Author Name
Mike Putman
Tweet Content
FAST trial, MMF vs MTX at the Review Course today Overall a big win for MTX, powered for noninferiority (bc people loved MMF) but looks like MTX won the day w/10% difference in outcomes Take home: MTX FTW per usual @RheumNow #ACR23 #ReviewCourse https://t.co/lY1V6S7X3d
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.